A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils

Parasite Immunology

Volumn 35, Issue 7-8, 2013, Pages 224-228

  Wilson, S ^a   Jones, F M ^a   Fofana, H K M ^b   Landoure A ^b   Kimani, G ^c   Mwatha, J K ^c   Sacko, M ^b   Vennervald, B J ^d   Dunne, D W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Institut National de Recherche en Sante Publique Mali   (Mali)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d DANISH BILHARZIASIS LABORATORY   (Denmark)

Author keywords

Eosinophils; Helminth; Human; IL 13; IL 33; Schistosomiasis; ST2

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 33; PARASITE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHISTOSOMA HEMATOBIUM; SCHOOL CHILD; UPREGULATION;

EOSINOPHILS; HELMINTH; HUMAN; IL-13; IL-33; SCHISTOSOMIASIS; ST2;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-5; INTERLEUKINS; MALE; PRAZIQUANTEL; RECEPTORS, CELL SURFACE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMICIDES; UP-REGULATION; YOUNG ADULT;

MALIA; MURINAE; SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; VERMES;

EID: 84879818063     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12035     Document Type: Article

References (28)

1. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479-490.
2. Moussion C, Ortega N & Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008; 3: e3331.
3. Lingel A, Weiss TM, Niebuhr M, et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 2009; 17: 1398-1410.
4. Moritz DR, Rodewald HR, Gheyselinck J & Klemenz R. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol 1998; 161: 4866-4874.
5. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N & Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009; 113: 1526-1534.
6. Cherry WB, Yoon J, Bartemes KR, Iijima K & Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008; 121: 1484-1490.
7. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367-1370.
8. Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12: 1055-1062.
9. Turnquist HR, Sumpter TL, Tsung A, et al. IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. J Immunol 2008; 181: 62-72.
10. Lohning M, Stroehmann A, Coyle AJ, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A 1998; 95: 6930-6935.
11. Hayakawa H, Hayakawa M, Kume A & Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007; 282: 26369-26380.
12. Khan WI, Blennerhasset P, Ma C, Matthaei KI & Collins SM. Stat6 dependent goblet cell hyperplasia during intestinal nematode infection. Parasite Immunol 2001; 23: 39-42.
13. Hasnain SZ, Evans CM, Roy M, et al. Muc5ac: a critical component mediating the rejection of enteric nematodes. J Exp Med 2011; 208: 893-900.
14. Akiho H, Blennerhassett P, Deng Y & Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2002; 282: G226-G232.
15. Hagan P, Wilkins HA, Blumenthal UJ, Hayes RJ & Greenwood BM. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol 1985; 7: 625-632.
16. Kimani G, Chunge CN, Butterworth AE, et al. Eosinophilia and eosinophil helminthotoxicity in patients treated for Schistosoma mansoni infections. Trans R Soc Trop Med Hyg 1991; 85: 489-492.
17. Fitzsimmons CM, Joseph S, Jones FM, et al. Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E. Infect Immun 2004; 72: 4023-4030.
18. Wilson S, Jones FM, Fofana HKM, et al. Rapidly boosted plasma IL-5 induced by treatment of human schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils. PLoS Negl Trop Dis 2013; 7: e2149.
19. Savinko T, Matikainen S, Saarialho-Kere U, et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 2012; 132: 1392-1400.
20. Lefrancais E, Roga S, Gautier V, et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A 2012; 109: 1673-1678.
21. Kakkar R, Hei H, Dobner S & Lee RT. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 2012; 287: 6941-6948.
22. Chow JY, Wong CK, Cheung PF & Lam CW. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation. Cell Mol Immunol 2010; 7: 26-34.
23. Woerly G, Lacy P, Younes AB, et al. Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol 2002; 72: 769-779.
24. Rankin AL, Mumm JB, Murphy E, et al. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 2010; 184: 1526-1535.
25. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D & Liew FY. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 2010; 185: 3472-3480.
26. Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F & Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 2002; 169: 4604-4612.
27. Kim BS, Siracusa MC, Saenz SA, et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013; 5: 170ra116.
28. Fitzsimmons CM, Jones FM, Stearn A, et al. The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses. PLoS Negl Trop Dis 2012; 6: e1593.